Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/α(m)β2-integrin glycoprotein

Critical Reviews in Immunology

Volumn 20, Issue 3, 2000, Pages 197-222

  Ross, G D ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

glucan; Complement receptor; Glycosylphospha tidylinositol (GPI) anchored receptor; Lectin; Neutrophil; Phagocytosis

Indexed keywords

BETA GLUCAN; CELL ADHESION MOLECULE; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; GLYCOPROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; INTEGRIN; LECTIN;

AUTOIMMUNE DISEASE; CELL ADHESION; CYTOTOXICITY; DEGRANULATION; ENDOTHELIUM; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; CELL ADHESION; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; GLUCANS; GLYCOPROTEINS; HUMANS; LECTINS; MACROPHAGE-1 ANTIGEN; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

EID: 0033836315     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (245)

1. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
2. Emerging paradigms of integrin ligand binding and activation
3. Receptor-receptor interactions of complement receptor type 3 in neutrophil membranes
4. Cooperation between CR1 (CD35) and CR3 (CD11b/CD18) in the binding of complement-opsonized particles
5. Roles of the integrins CR3 and CR4 in disease and therapeutic strategies
6. Where the outside meets the inside: Integrins as activators and targets of signal transduction cascades
7. Signaling mechanisms and the activation of leukocyte integrins
8. 3) for β-glucans
9. Role of complement receptor type three and serum opsonins in the neutrophil response to yeast
10. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands
11. 2 integrin
12. Functional mapping of CD11b/CD18 epitopes important in neutrophil-epithelial interactions: A central role of the I domain
13. Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18)
14. Generation of recombinant fragments of CD11b expressing the functional β-glucan-binding lectin site of CR3 (CD11b/CD18)
15. Integrins as promiscuous signal transduction devices
16. LPS induces CD14 association with complement receptor type 3, which is reversed by neutrophil adhesion
17. 2(CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors
18. Cross-linking of CD59 promotes CR3 dependent adherence of PMN to fibronectin and endothelial cells
19. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes
20. Isolation and purification of a cell adhesion factor from crayfish blood cells
21. In vitro induction of cecropin genes - An immune response in a Drosophila blood cell line
22. Recognition of yeast cell wall glucan by Atlantic salmon (Salmos salar L.) macrophages
23. Phagocytosis and invertebrate opsonins in relation to parasitism
24. Phylogeny of the third complement component, C3, and conservation of C3-ligand interactions
25. A cell-surface opsonic receptor on leucocytes from the phylogenetically primitive vertebrate, Eptatretus stouti
26. Sea urchin coelomocytes specifically express a homologue of the complement component C3
27. Coelomocytes express SpBf, a homologue of factor B, the second component in the sea urchin complement system
28. Cytolytic lymphocytic cells with complement receptor in human blood. Induction of cytolysis by IgG antibody but not by target cell-bound C3
29. Role of binding through C3b and IgG in polymorphonuclear neutrophil function: Studies with trypsin-generated C3b
30. The role of C3 fragments in endocytosis and extracellular cytotoxic reactions by polymorphonuclear leukocytes
31. Tumor-promoting phorbol esters stimulate C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes
32. Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or NK cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells
33. The β-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells
34. β-Glucan, a 'specific' biologic response modifier that uses antibodies to target tumors for recognition by complement receptor type 3 (CD11b/CD18)
35. Therapeutic intervention with complement and β-glucan in cancer
36. A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits
37. Inhibition of CD18-dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates
38. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function
39. 2 integrins of rat neutrophils in complement- and oxygen radical-mediated acute inflammatory injury
40. Both anti-CD11a (LFA-I) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis
41. Folding of the N-terminal, ligand-binding region of integrin α-subunits into a β-propeller domain
42. Experimental support for a β-propeller domain in integrin α-subunits and a calcium binding site on its lower surface
43. The structure of the β-propeller domain and C-terminal region of the integrin α(M) subunit - Dependence on β subunit association and prediction of domains
44. The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) α subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B
45. Functional interaction between the integrin antagonist neutrophil inhibitory factor and the I domain of CD11b/CD18
46. Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18)
47. Two conformations of the integrin A-domain (I-domain): A pathway for activation?
48. 2+-complexed crystal structures
49. Cation binding to the integrin CD11b I domain and activation model assessment
50. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen
51. 2 that differentially affect a divalent cation-dependent conformation
52. Conformational changes in tertiary structure near the ligand binding site of an integrin I domain
53. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble β-glucan
54. Energetics of leukocyte integrin activation
55. 2 ligand interactions
56. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation
57. Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface
58. CD11b and CD11c antigens are rapidly increased on human natural killer cells upon activation
59. CR3 (CD11b/CD18) expressed by cytotoxic T cells and NK cells is upregulated in a manner similar to neutrophils following stimulation with various activating agents
60. Ectodomain interactions of leukocyte integrins and pro-inflammatory GPI-linked membrane proteins
61. 2 integrins in vivo
62. Regulation of leukocyte adherence and migration by glycosylphosphatidylinositol-anchored proteins
63. 4) activity resembling CR3
64. Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa
65. The respiratory burst response to Histoplasma capsulatum by human neutrophils: Evidence for intracellular trapping of superoxide anion
66. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins
67. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-γ activation inhibits complement receptor function and phagocytosis of this bacterium
68. Macrophage cytoskeleton association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes
69. Binding of Cryptococcus neoformans to heterologously expressed human complement receptors
70. Complement-dependent clearance of apoptotic cells by human macrophages
71. Role of CR4 in Mycobacterium tuberculosis-human macrophages binding and signal transduction in the absence of serum
72. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies
73. + cells as possible candidates for immature dendritic cells in the murine Peyer's patches
74. Murine macrophages lack expression of the Cr2-145 (CR2) and Cr2-190 (CR1) gene products
75. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1- deficient mice
76. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration
77. Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1
78. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide
79. Role of the adherence-promoting receptors, CR3, LFA-1, and p150, 95, in binding of Histoplasma capsulatum by human macrophages
80. 2 integrins on bovine leukocytes
81. Neutrophil C3bi receptors: Formation of membrane clusters during cell triggering requires intracellular granules
82. An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors
83. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils
84. Adhesomes: Specific granules containing receptors for laminin, C3bi/fibrinogen, fibronectin, and vitronectin in human polymorphonuclear leukocytes and monocytes
85. Neutrophil CR3 expression and specific granule exocytosis are controlled by different signal transduction pathways
86. Phorbol ester induces transient focal concentrations of functional, newly expressed CR3 in neutrophils at sites of specific granule exocytosis
87. T cell adhesion to intercellular adhesion molecule-1 (ICAM-1) is controlled by cell spreading and the activation of integrin LFA-1
88. The I domain of integrin leukocyte function-associated antigen-1 is involved in a conformational change leading to high affinity binding to ligand intercellular adhesion molecule 1 (ICAM-1)
89. Dissociation between increased surface expression of gp165/95 and homotypic neutrophil aggregation
90. Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18)
91. Activation of phagocytic cells' C3 receptors for phagocytosis
92. Aggregation of complement receptors on human neutrophils in the absence of ligand
93. Enhancement of the function of neutrophil type-1 and type-3 complement receptors by human leukocyte inhibitory factor (LIF)
94. Different signaling pathways for CD18-mediated adhesion and Fc-mediated phagocytosis: Response of neutrophils to LPS
95. Complement receptor-mediated phagocytosis is associated with accumulation of phosphatidylcholine-derived diglyceride in human neutrophils. Involvement of phospholipase D and direct evidence for a positive feedback signal of protein kinase C
96. 2 and NADPH oxidase
97. Phorbol esters cause sequential activation and deactivation of complement receptors on polymorphonuclear leukocytes
98. Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation
99. 3)
100. Regulation of interleukin-12 by complement receptor 3 signaling
101. Selective suppression of interleukin-12 induction after macrophage receptor ligation
102. Monocyte induction of IL-10 and downregulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin
103. 2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm-derived neutrophil adhesion inhibitor NIF
104. Solvent-accessible residues on the metal ion-dependent adhesion site face of integrin CR3 mediate its binding to the neutrophil inhibitory factor
105. Polymorphonuclear leucocyte (PMN) inhibitory factor prevents PMN-dependent endothelial cell injury by an anti-adhesive mechanism
106. 2 integrins
107. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes
108. Function of the urokinase receptor (CD87) in neutrophil chemotaxis
109. Identification of a reticuloendothelial stimulating agent in zymosan
110. Architecture of the yeast cell wall. The linkage between chitin and β(1→3)-glucan
111. Two different conformations of the antitumor β-D-glucan produced by Sclerotinia sclerotiorum IFO 9395
112. Development of a water-soluble, sulfated (1→3)-β-D-glucan biological response modifier derived from Saccharomyces cerevisiae
113. Comparison of the blood clearance of triple- and single- helical schizophyllan in mice
114. Antitumor activity of degraded products of lentinan: Its correlation with molecular weight
115. 3
116. A β-glucan inhibitable receptor on human monocytes: Its identity with the phagocytic receptor for particulate activators of the alternative complement pathway
117. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte β-glucan receptor
118. Isolation of a yeast heptaglucoside that inhibits monocyte phagocytosis of zymosan particles
119. Lectin-like inhibition of immune complex receptor-mediated stimulation of neutrophils: Effects on cytosolic calcium release and superoxide production
120. Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte β-glucan receptors
121. Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicans
122. β-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage
123. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan - Mannose receptor-mediated phagocytosis initiates IL-12 production
124. 3) has lectin-like properties analogous to bovine conglutinin and functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b
125. Detection of transmembrane linkages between immunoglobulin or complement receptors and the neutrophil's cortical microfilaments by resonance energy transfer microscopy
126. Cocapping of the leukoadhesin molecules complement receptor type 3 and lymphocyte function-associated antigen-1 with Fcγ receptor III on human neutrophils: Possible role of lectin-like interactions
127. Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fcγ receptor IIIB and the complement receptor type 3
128. Deficiency of a surface membrane glycoprotein (Mol) in man
129. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol)
130. 2 integrins
131. Distinct tyrosine kinase activation and Triton X-100 insolubility upon FcγRII or FcγRIIIB ligation in human polymorphonuclear leukocytes. Implication for immune complex activation of the respiratory burst
132. 2; CD11b/CD18) restores IgG-dependent phagocytosis in transfectants expressing a phagocytosis-defective FcγRIIA (CD32) tail-minus mutant
133. A role for Mac-1 (CD11b/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcγ receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis
134. 2, Mac-1): Indirect effects of an ARG- GLY-ASP (RGD) sequence
135. Outside-in signaling by lipopolysaccharide through a tailless integrin
136. Human phagocytes have multiple lipid A-binding sites
137. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors
138. Toll, a new piece in the puzzle of innate immunity
139. Tlr4: Central component of the sole mammalian LPS sensor
140. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide
141. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells
142. Mechanisms of pertussis toxin-induced myelomonocytic cell adhesion: Role of Mac-1 (CD11b/CD18) and urokinase receptor (CD87)
143. Impaired migration in vitro of neutrophils from patients with paroxysmal nocturnal haemoglobinuria
144. Regulation of integrin function by the urokinase receptor
145. 2) and urokinase receptors on migrating neutrophils
146. 2; CD11c/CD18) oscillations on neutrophils in a mild form of pyoderma gangrenosum
147. Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: Recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit
148. De novo synthesis of diacylglycerol from glucose. A new pathway of signal transduction in human neutrophils stimulated during phagocytosis of β-glucan particles
149. Receptor-mediated phagocytosis in human neutrophils is associated with increased formation of inositol phosphates and diacylglycerol. Elevation in cytosolic free calcium and formation of inositol phosphates can be dissociated from accumulation of diacylglycerol
150. Single pulses of cytoplasmic calcium associated with phagocytosis of individual zymosan particles by macrophages
151. Calcium signaling capacity of the CD11b/CD18 integrin on human neutrophils
152. 2 avidity in polymorphonuclear neutrophils
153. Urokinase receptor (CD87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes
154. 2+ influx in human neutrophils undergoing CD11b/CD18 integrin engagement
155. Impediment to calcium influx and reactive oxygen production accounts for the inhibition of neutrophil Mac-1 upregulation and adhesion by tetrandrine
156. A role for MARCKS, the α isozyme of protein kinase C and myosin I in zymosan phagocytosis by macrophages
157. Zymosan-triggered association of tyrosine phosphoproteins and lyn kinase with cytoskeleton in human monocytes
158. Phosphorylation of the β-subunit of CD11/CD18 integrins by protein kinase C correlates with leukocyte adhesion
159. Effect of a selective protein kinase C inhibitor, Ro 31-8425, on Mac-1 expression and adhesion of human neutrophils
160. 7 integrin activity
161. 'Outside-in' signalling mechanisms underlying CD11b/CD18-mediated NADPH oxidase activation in human adherent blood eosinophils
162. Activation of p58(c-fgr) and p53/56(lyn) in adherent human neutrophils: Evidence for a role of divalent cations in regulating neutrophil adhesion and protein tyrosine kinase activities
163. CD63 associates with tyrosine kinase activity and CD11/CD18, and transmits an activation signal in neutrophils
164. CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion
165. MacMARCKS mutation blocks macrophage phagocytosis of zymosan
166. Adhesion-dependent protein tyrosine phosphorylation in neutrophils treated with tumor necrosis factor
167. 2 integrin-dependent tyrosine phosphorylation of paxillin in human neutrophils treated with tumor necrosis factor
168. 2 integrins mediate protein tyrosine phosphorylation in human neutrophils
169. 2 integrin triggers activation and degranulation of human eosinophils
170. Activation of complement receptor 3 on human monocytes by cross-linking of very-late antigen-5 is mediated via protein tyrosine kinases
171. Phosphatidylinositol 3-kinase mediates chemoattractant-stimulated, CD11b/CD18-dependent cell-cell adhesion of human neutrophils: Evidence for an ERK-independent pathway
172. 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst
173. 2-integrins
174. 2 integrin phosphorylation: Regulation of neutrophil aggregation involves a phosphatase-dependent pathway
175. Mac-1 (CD11b/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate
176. The protein tyrosine phosphatase SHP-1 regulates integrin-mediated adhesion of macrophages
177. Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules
178. Targeting of NK cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and β-glucan-primed CR3 (CD11b/CD18)
179. Two functional domains in the phagocyte membrane glycoprotein Mol identified with monoclonal antibodies
180. Differential ligand binding specificities of recombinant CD11b/CD18 integrin I-domain
181. Evidence for in vivo reaction of antibody and complement to surface antigens of human cancer cells
182. Immunoglobulins, complement and foreign antigens in human tumor cells
183. Immunofluorescent study of immunoglobulins and complement components in human brain tumors
184. Persistent complement activation on tumor cells in breast cancer
185. Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence
186. Generation of human monoclonal antibodies reactive with human mammary carcinoma cells
187. Natural anti-lymphoma activity in C57BL/6 mice: Time course of appearance and nature of cytotoxic antibodies
188. Natural antibodies to cell-surface antigens of human astrocytoma
189. Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer
190. Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity
191. Complement activation on human neuroblastoma cell lines in vitro: Route of activation and expression of functional complement regulatory proteins
192. Effect of glucan on mouse sarcoma 37
193. Antitumor action of some Basidiomycetes, especially Phllinus inteus
194. Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) Sing
195. Host-mediated antitumor action of schizophyllan, a glucan produced by Schizophyllum commune
196. Response of tumors to biologic modifiers and chemotherapeutic agents
197. Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer - A randomized comparative study by an envelop method
198. Clinical evaluation of schizophyllan adjuvant immunochemotherapy for patients with resectable gastric cancer - A randomized controlled trial
199. Lentinan potentiates immunity and prolongs the survival time of some patients
200. Treatment of head and neck cancers with BRMs - Prolongation of survival
201. Adjuvant therapy of gastric cancer: The Japanese experience
202. Intratumoral administration of sizofiran activates langerhans cell and T-cell infiltration in cervical cancer
203. ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18)
204. Intercellular adhesion molecule-2 (CD102) binds to the leukocyte integrin CD11b/CD18 through the A domain
205. Oligospecificity of the cellular adhesion receptor MAC-1 encompasses an inducible recognition specificity for fibrinogen
206. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen
207. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18)
208. The leukocyte integrin Mac-1 (CD11b/CD18) contributes to binding of human granulocytes to collagen
209. Identification of haptoglobin as an alternative ligand for CD11b/CD18
210. 2 (CD11b/CD18)
211. Generation of leukotrienes by human monocytes upon stimulation of their β-glucan receptor during phagocytosis
212. 4 production
213. Role of endogenously derived leukotrienes in the regulation of lysosomal enzyme expression in macrophages exposed to β1,3-glucan
214. 2 production but not antigen-presenting function
215. Stimulation of human monocyte β-glucan receptors by glucan particles induces production of TNF-α and IL-1β
216. Zymosan-stimulated tumor necrosis factor-α production by human monocytes: Down-modulation by phorbol ester
217. Pneumocystis carinii stimulates tumor necrosis factor-a release from alveolar macrophages through a β-glucan-mediated mechanism
218. Production of prostaglandin E2 and interleukin-1 by mouse peritoneal macrophages stimulated with β-1,3-D-glucan derivatized plastic beads
219. Expression of interleukin-1 family mRNAs by a highly branched (1→3)-β-D-glucan, OL-2
220. Enhancement of cytokine production by macrophages stimulated with (1→3)-β-D-glucan, Grifolan (GRN), isolated from Grifola frondosa
221. Soluble Fcγ receptor type III (FcγRIII, CD16) triggers cell activation through interaction with complement receptors
222. Mouse CD23 regulates monocyte activation through an interaction with the adhesion molecule CD11b/CD18
223. 4 and neutrophil attractant/activation protein (interleukin-8) sequentially in response to stimulation with LPS and zymosan
224. Zymosan-induced IL-8 release from human neutrophils involves activation via the CD11b/CD18 receptor and endogenous platelet-activating factor as an autocrine modulator
225. Cytokine synthesis of human monocytes stimulated by triple or single helical conformer of an antitumour (1→3)-β-D-glucan preparation, sonifilan
226. 2 integrins (CD11/CD18) in the regulation of cytokine gene expression of polymorphonuclear neutrophils during the inflammatory response
227. Stimulation of tumor-localized NK Cell cytokine secretion by β-glucan priming of CR3 (CD11b/CD18) for cytotoxic recognition of tumor-restricted iC3b
228. Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: Identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression
229. Ligand binding by the p150,95 antigen of U937 cells: Properties in common with complement receptor type 3 (CR3)
230. 2 integrins can generate different ligand binding states
231. Effect of antibodies directed against complement receptors on phagocytosis by polymorphonuclear leukocytes: Use of iodination as a convenient measure of phagocytosis
232. Immunological mapping of the human leucocyte adhesion glycoprotein gp90 (CD18) by monoclonal antibodies
233. Antibody against the Leu-CAM β-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events
234. Regulated expression of the Mac-1, LFA-1, p150,95 glycoprotein family during leukocyte differentiation
235. Antigenic relationship between the alpha-chain of C3, a leucocyte-surface antigen involved in the activation of phagocytic cells, and a 50,000 MW B-cell antigen
236. An anti-human monocyte/macrophage monoclonal antibody, reacting most strongly with macrophages in lymphoid tissue
237. 2+ binding epitope on leukocyte integrin a subunits
238. The distribution of the CR3 receptor on human cells and tissue as revealed by a monoclonal antibody
239. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies
240. Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 α-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored FcγRIIIB (CD16) molecules
241. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo
242. Mac-1: A macrophage differentiation antigen identified by monoclonal antibody
243. Mapping of antigenic and functional epitopes on the α- and β-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1